TASC commercial portfolio
Tayside has continued commitment to delivery and performance in an environment where the study mix is becoming more challenging and labour-intensive.
On this page
Studies in Tayside
Tayside has taken part in 174 commercial research studies in the past 5 years (2015-2020)
Our Tayside studies were in the following categories:
- 70% drug trials
- 10% questionnaire studies
- 8% medical device trials
- 8% limited to data
- 4% basic science and qualitative studies

Active therapy areas
Our most active therapy areas are:
- Cancer 24%
- Neuroprogressive and Dementia 18%
- Cardiovascular 14%
- Dermatology 10%
- Respiratory 9%
- Diabetes 8%
- and Paediatrics 6%

Study recruitment
We recruited 994 participants to trials in Tayside.
57% of our studies recruited to target and 24% over recruited (2018-2020)
